Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
TVAX Biomedical
ClinicalTrials.gov Identifier:
NCT01290692
First received: February 3, 2011
Last updated: September 16, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)